ProPlege

peripheral retrograde
cardioplegia device

ProPlege Device

Consistent delivery.
Global protection*.

Adding ProPlege retrograde cardioplegia to antegrade delivery offers global myocardial protection without disruption, expanding minimally invasive cardiac surgery to more patients.

* In conjunction with antegrade cardioplegia

ProPlege Benefits

ProPlege Benefits

Learn about the benefits of using the ProPlege device

Device Specifications

Device Specifications

Learn about the ProPlege indications and specifications

Device Prep

Device Prep

Review materials to assist in preparation of the ProPlege device

eLearning / VR

eLearning / VR

Access educational content related to the ProPlege device

Troubleshooting Materials

Troubleshooting Materials

Access content to assist in device placement

Stay connected

Register to receive the latest information
on product updates and educational events

Benefits of the ProPlege device

Global protection*, fewer complications

Global protection*,
fewer complications

Paired with antegrade cardioplegia, ProPlege can

  • More fully protect the heart1-4
  • Help reduce risks of complications, such as cardiac and neurological events1-4
  • Help patients come off bypass effectively for optimal hemodynamic return5,6

* In conjunction with antegrade cardioplegia

Maintain your momentum

Maintain your
momentum

Streamline your procedures with reliable, uninterrupted performance

  • Avoid redose disruption6
  • Eliminate retractor repositioning1
  • Avoid complex, inconsistent workarounds for each patient6,7
Designed for minimally-invasive surgery

Designed for
minimally-invasive surgery

Enables minimally invasive on-pump cardiac procedures

  • For more patients in a safer and more reliable manner than direct cannulation7,8
  • Delivers retrograde cardioplegia through a peripheral approach outside the operating window
  • With experience, anesthesiologists can reduce insertion time and optimize positioning6-10
ProPlege device

ProPlege device information

Select a link below to learn more.

Product brochure

Product brochure

ProPlege device IFU

ProPlege device IFU

ProPlege spec sheet

ProPlege spec sheet

Device description & specifications

The ProPlege peripheral retrograde cardioplegia device (ProPlege device) is a 9 Fr (3.1 mm), 59 cm long, triple-lumen, articulating device with an elastomeric balloon near its tip for occluding the coronary sinus for retrograde perfusion of the coronary circulation.

The ProPlege device is indicated for:

  • occlusion of the coronary sinus
  • delivery of retrograde cardioplegia solution
  • monitoring of coronary sinus pressure during cardiopulmonary bypass

Models & specifications

  • Model no. PR9
  • Catheter size – 9 Fr (3.1)
  • Effective length – 23.2 in (59 cm)
  • Overall length – 32.3 in (82 cm)
  • The ProPlege device is intended for use ONLY
    with a Cordis® AVANTI®+ 11 Fr introducer sheath

    • The Cordis® AVANTI®+ 11 Fr introducer sheath is sold separately by its manufacturer and is not included with the ProPlege device

ProPlege device educational resources

Select a link below to access.

ProPlege spec sheet

ProPlege spec sheet

ProPlege device IFU

ProPlege device IFU

Product brochure

Product brochure

ProPlege device prep video

Click the video for a demonstration on how to properly prepare the ProPlege peripheral retrograde cardioplegia catheter.

ProPlege device prep content

Select a link below to learn more.

ProPlege Prep Poster

ProPlege prep poster

ProPlege device IFU

ProPlege device IFU

Access the ProPlege
eLearning module

Learn about device features, preparation,
troubleshooting, and more.

Access the ProPlege eLearning module

ProPlege device VR simulation

Click the video to experience using the ProPlege catheter in virtual reality.

ProPlege device troubleshooting and educational content

Select a link below to learn more.

ProPlege troubleshooting cards

ProPlege troubleshooting cards

ProPlege device IFU

ProPlege device IFU

ProPlege echo reference cards

ProPlege echo reference cards

ProPlege Prep Poster

ProPlege prep poster

Product brochure

Product brochure

ProPlege spec sheet

ProPlege spec sheet

References

1. Miller GS, et al. J Cardiothor Vasc Anes. 2010;24:743-5. 2. Khan AH, et al. J Cardiovasc Dis. 2015;13:10-4. 3. Loop FD, et al. J Thorac Cardiovasc Surg. 1992;104:608-18. 4. Dagenais F, et al. Ann Thorac Surg. 1999;68:1681-5. 5. Cernaianu AC, et al. Tex Heart Inst J. 1996;23:9-14. 6. Labriola C, et al. J Cardiothor Vasc Anes. 2017;31:1203-9. 7. Labriola C, et al. J Cardiothor Vasc Anes. 2015;29;598-604. 8. Lebon JS, et al. J Cardiothor Vasc Anes. 2019;33:1197-1204. 9. Ward AF, et al. J Thorac Cardiovasc Surg. 2014;148:2769-72. 10. Samarani G, et al. Am J Resp Crit Care Med. 2018;197:MeetingAbstracts.

Stay Connected

Please fill out this form to receive the latest information and updates from enableCV. 

Important Safety Information

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

The ProPlege device is manufactured by enableCV, Inc., 6967 S. River Gate Dr., Suite 104 Midvale, UT 84047.

enableCV, the stylized enableCV logo, and ProPlege are trademarks of enableCV, Inc. and its affiliates. All other trademarks are the property of their respective owners. ECV-SM-0008 01